Repression of Heat Shock Transcription Factor HSF1 Activation by HSP90 (HSP90 Complex) that Forms a Stress-Sensitive Complex with HSF1  by Zou, Jiangying et al.
Cell, Vol. 94, 471±480, August 21, 1998, Copyright 1998 by Cell Press
Repression of Heat Shock Transcription Factor
HSF1 Activation by HSP90 (HSP90 Complex)
that Forms a Stress-Sensitive Complex with HSF1
the inactive state in the absence of stress and/or in
returning the factor to this state following a stressful
event (Lindquist, 1980; DiDomenico et al., 1982; Abra-
vaya et al., 1991; Baler et al., 1992, 1996; Mosser et al.,
1993). It was proposed that Hsp/c70 may function as a
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repressor of HSF1 activation. Nonnative proteins accu-²Department of Pharmacology
mulating during stress may compete with HSF1 for bind-University of Nebraska Medical Center
ing chaperone Hsp/c70, and unbound HSF1 may homo-Omaha, Nebraska 68198-6260
trimerize and acquire transcriptional competence (Craig
and Gross, 1991; Abravaya et al., 1992; Baler et al.,
1992, 1996). However, this role of Hsp/c70 has remainedSummary
tentative, and it appears equally possible that another
chaperone(s) or chaperone complex(es) may be the re-Heat shock and other proteotoxic stresses cause ac-
pressor of HSF1. Hsp90, Hsp40, CyP40, FKBPs, andcumulation of nonnative proteins that trigger activa-
p23 are all known to have chaperoning activity (Bose ettion of heat shock protein (Hsp) genes. A chaperone/
al., 1996; Freeman et al., 1996). Hsp90 participates inHsp functioning as repressor of heat shock transcrip-
the formation of multichaperone complexes that bindtion factor (HSF) could make activation of hsp genes
target proteins such as steroid receptors (Catelli et al.,dependent on protein unfolding. In a novel in vitro
1985; Sanchez et al., 1985; Schuh et al., 1985; Pratt,system, in which human HSF1 can be activated by
1993; Smith and Toft, 1993; Nair et al., 1996) and severalnonnative protein, heat, and geldanamycin, addition
protein kinases. One such multichaperone complex, re-of Hsp90 inhibits activation. Reduction of the level of
ferred to herein as Hop complex, includes Hsp90, Hsp/Hsp90 but not of Hsp/c70, Hop, Hip, p23, CyP40, or
c70, and Hop and transiently associates with Hip. An-Hsp40 dramatically activates HSF1. In vivo, geldana-
other group of multichaperone complexes are the p23mycin activates HSF1 under conditions in which it is
complexes that contain Hsp90, p23, and a third proteinan Hsp90-specific reagent. Hsp90-containing HSF1
such as CyP40 or an FKBP (for reviews see Smith andcomplex is present in the unstressed cell and dissoci-
Toft, 1993; Frydman and Hoehfeld, 1997).ates during stress. We conclude that Hsp90, by itself
Interestingly, Hsp90 affinity chromatography experi-and/or associated with multichaperone complexes, is
ments suggested that Hsp90 can interact with HSF1a major repressor of HSF1.
(Nadeau et al., 1993), and reconstitution assays using
recombinant (trimeric) human HSF1 showed that Hsp40,Introduction
Hsp90, and Hsp90 multichaperone complex constit-
uents Hsp/c70, Hop, Hip, p23, CyP40, and FKBPs haveTranscription of heat shock protein (Hsp) genes and,
a propensity for associating with HSF1 (Nair et al., 1996;
consequently, synthesis of Hsps are enhanced upon
Voellmy, 1996, and unpublished data). Furthermore, cer-
exposure of cells to a proteotoxic stress, including heat
tain benzoquinone ansamycins such as geldanamycin
shock. In vertebrate species, this transcriptional en-
and herbimycin A specifically bind Hsp90 (Whitesell et
hancement is due to the activation of heat shock tran-
al., 1994) and disrupt p23 complexes in vitro and in vivo
scription factor 1 (HSF1), one of four related factors
(Smith et al., 1995; Whitesell and Cook, 1996). The same
capable of specifically binding heatshock element (HSE)
compounds also activate HSF1 in vivo (Hedge et al.,
sequences present in hsp promoters. In extract from 1995; Zou et al., 1998). This observation raises the possi-
unstressed cells, HSF1 is found predominantly as a mo-
bility that Hsp90 may participate in the negative regula-
nomeric polypeptide that lacks specific DNA-binding
tion of HSF1. However, since geldanamycin and herbi-
activity. A small fraction of HSF1 appears in a binary
mycin A are also potent redox cyclers and may cause
complex with Hsp/c70. When cells are stressed, HSF1 oxidative protein denaturation (Zou et al., 1998), it has
homotrimerizes, acquires DNA-binding activity, translo- remained uncertain whether their activating effect is di-
cates from the cytoplasm to the nucleus, is hyperphos- rectly related to their ability to bind Hsp90.
phorylated, and becomes transcriptionally competent In this paper we investigate whether Hsp90 or another
(Morimoto et al., 1996; Voellmy, 1996; Nakai et al., 1997). constituent of Hsp90-containing multichaperone com-
The mechanism of stress activation of HSF1 is not plexes is a repressor of HSF1 activation. Chaperones
yet understood. However, previous work provided two are generally present at high levels in the unstressed
important clues. First, stress induces protein unfolding, cell. Hsp90 is the most abundant chaperone, constitut-
which results in accumulation of nonnative protein. Non- ing about 1%±2% of total protein (Jakob and Buchner,
native protein appears to be the common proximal in- 1994). Thus, it would be difficult to substantially overex-
ducer of HSF1 activity and enhanced hsp gene expres- press chaperones, particularly Hsp90. In addition, chap-
sion in the stressed cell (Kelley and Schlesinger, 1978; erones tend to be long-lived proteins, and inhibition of
Hightower, 1980; Ananthan et al., 1986). Second, an Hsp, their expression would only slowly reduce their concen-
possibly Hsp/c70, may play a role in retaining HSF1 in tration. Associated chaperones generally serve to stabi-
lize their target proteins (Whitesell and Cook, 1996;
Whitesell et al., 1997) and, as has been shown in the³To whom correspondence should be addressed.
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case of steroid receptors, maintain them in an inactive
but activation-competent conformation (Picard et al.,
1990; Scherrer et al., 1992; Nathan and Lindquist, 1995).
By analogy, a slow decline in the concentration of rele-
vant chaperones may destabilize inactive HSF1. In con-
trast, chaperones may become rapidly unavailable for
binding HSF1 during stress, resulting in a sharp increase
in the concentration of unbound HSF1. Because of the
strong concentration dependence of the HSF1 trimeriza-
tion reaction (Larson et al., 1988), factor trimerization
may be favored over inactivation/degradation in this sit-
uation. To avoid these predictable difficulties of in vivo
approaches to identify HSF1 repressor, we developed
an in vitro system that recapitulates the initial step of
HSF1 activation in vivo.
Results
An In Vitro System that Reproduces the Initial Step
of HSF1 Activation
A lysate system (activation lysate) was established that
reproduces the earliest step in HSF1 activation in vivo,
which is the conversion of inactive, nontrimeric factor to
trimeric factor capable of binding HSE DNA. The criteria
chosen for validation of the system were induction by
heat shock, the classical inducer of Hsp expression, by
denatured protein, the common proximal inducer of Hsp
expression during stress, and by the Hsp90-binding
compound geldanamycin.
Figure 1. Activation of HSF1 In Vitro by Heat Shock
Activation lysate, prepared as described in Experi-
(A±E, G, and H) EMSA of aliquots of activation lysate. RT, roommental Procedures, was exposed for 5 min to different
temperature; THS, threshold heat shock; HS, heat shock; CHM,
temperatures between 08C and 458C (Figure 1A). HSE cycloheximide; bac-HSF1, baculovirus-expressed HSF1; E. coli-
DNA-binding activity was assessed by electrophoretic HSF1, bacterially expressedHSF1. In (C) EMSA used either a radiola-
beled LexA binding site-containing probe (LexA probe) or an HSEmobility shift assay (EMSA), using a radiolabeled HSE
DNA probe (all other lanes). HSE DNA, 25-fold excess of unlabeledoligonucleotide probe. Note that our gels typically re-
HSE probe; HSF1 Ab, HSF1 antibody. In (G) reactions were withsolved two or more distinct HSE DNA-HSF complexes.
activation lysate lacking ATP-regenerating system.HSE DNA-binding activity increased gradually with tem-
(F) Native anti-HSF1 blot of activation lysate. In vivo: extract from
peratures up to 418C and more sharply between 418C HeLa cells exposed to 428C for 45 min. M, HSF1 monomers; D,
and 438C. The temperature at which the latter, more HSF1-Hsp/c70 heterodimers; T, HSF1 trimers. Note that different
panels show results from independent assays involving independentdiscrete increase occurred varied somewhat between
exposures of gels.experiments (between 378C and 418C). Cells sense the
severity of a heat stress, which is a function of both
temperature and duration of exposure (DiDomenico et
al., 1982). As in vivo, HSE DNA-binding activity of activa- therefore, most readily influenced by changes in experi-
mental parameters under threshold activation condi-tion lysate increased with exposure time at all but the
highest temperatures (Figure 1B: exposure at 278C). tions. Therefore, activation lysate was routinely incu-
bated at 278C±298C for 60 min (threshold heat shock),Thus, the in vitro system is capable of sensing heat
stress, although DNA-binding activity increases with which resulted in a minor but clearly detectable increase
in HSF1 DNA-binding activity. Where appropriate (indi-temperature more gradually in vitro than in vivo. The
latter difference may be explained, in part, by the obser- cated in figures and legends), reactions incubated for
60 min at room temperature (basal level of activation)vation (see below) that HSF1 activation is a reversible
process in vivo but not in vitro. or 378C (heat shock condition inducing substantial DNA-
binding activity) were analyzed for comparison. RelativeThe heat-activated factor binds the HSE DNA probe
but not an unrelated oligonucleotide probe (Figure 1C). DNA-binding activities induced by the three conditions
are shown in Figure 1E. Relative amounts of HSF1 tri-Furthermore, a 25-fold excess of unlabeled HSE DNA
suppressed binding to the HSE probe (in the presence mers formed were estimated by native anti-HSF1 blot
(Figure 1F).of a 500-fold excess of nonspecific DNA). Thus, heat
treatment induced the DNA-binding activity of an HSF Since processes involving chaperones are generally
ATP-dependent, activation lysate was routinely preincu-that was identified as HSF1 by HSF1 antibody supershift
(Figure 1C). As in vivo (Zimarino and Wu, 1987), heat bated with an ATP-regenerating system (see Experimen-
tal Procedures). That activation of HSF1 is, in fact, de-activation of HSF1 in vitro was independent of protein
synthesis (Figure 1D). pendent on the presence of ATP was confirmed by the
experiment in Figure 1G.HSF1 regulation was expected to be least stable and,
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al., 1995). A similar observation was made for activation
of HSF1 by denatured proteins (discussed below). These
findings may reflect the temperature dependence of the
HSF1 trimerization reaction. Use was made of this prop-
erty of the in vitro system to further probe the notion
that HSF1 activation by geldanamycin occurred as a
consequence of the compound's interaction with Hsp90.
Activation lysate was incubated with geldanamycin for
20 min at room temperature, which was expected to
result in binding of the compound to Hsp90 and latent
activation of HSF1 (Figure 2E). To allow trimerization to
occur (here measured as DNA-binding activity), lysate
was then subjected to threshold heat shock. Addition of
purified Hsp90 immediately prior to the latter incubation
greatly reduced the extent of HSF1 activation by gelda-
namycin (Hsp90 also suppressed the low-level acti-
vation occurring in the absence of geldanamycin, but
see below for a more extensive analysis of this aspect).
Figure 2. Activation of HSF1 by Geldanamycin That trimerization does not occur at room temperature
(A,B,D, and E) EMSA of activation lysate. GA, geldanamycin; MAC, was also exploited in an experiment demonstrating that
macbecin II; FGA, 1,9-formyl geldanamycin; co Ab, rabbit preim- geldanamycin greatly increases the protease sensitivity
mune serum; DTT, 10 mM dithiothreitol; Hsp90, 2 mg/ml Hsp90.
of inactive HSF1 (Figure 2F; see Experimental Proce-(C) Native anti-HSF1 blot of activation lysate.
dures for details of protocol). Taken together, the re-(F) Anti-HSF1 Western blot of lysate incubated with chymotrypsin.
sults of the latter two experiments suggest that inactiveFull-length HSF1 is indicated by arrow. See Figure 1 for other details.
HSF1 is bound by Hsp90 and that this association pre-
vents and its interruption promotes factor trimerization.
Activation of HSF could result from either an increased Note that in the above experiments geldanamycin was
rate of HSF trimerization or a reduced rate of trimer used at 50 mg/ml to produce maximal effects. Activa-
dissociation, or both. To find out which reaction was tion of HSF1 was detected at concentrations as low as
affected by heat shock, we tested whether dissociation 2 mg/ml.
of HSF1 trimers could occur in activation lysate. Trimeric To find out whether HSF1 could be activated by non-
recombinant HSF1 was added to activation lysate in native proteins in our in vitro system, chemically dena-
amounts approximatelycomparable to endogenous HSF1 tured bovine serum albumin (CM-BSA) and activation
(estimated from EMSA of recombinant HSF1 and heat-
lysate (CM-extract) were prepared by denaturation in
treated activation lysate). Reactions were incubated for
urea and reductive carboxymethylation (Ananthan et al.,
up to 3 hr at room temperature (Figure 1H) or threshold
1986). Addition of these preparations of denatured pro-
heat shock temperature (data not shown). EMSA re-
tein to activation lysate (at 0.4 mg/ml) strongly stimu-
vealed no decrease in DNA-binding activity and, there-
lated HSE DNA-binding activity, whereas comparable
fore, in the concentration of recombinant HSF1 trimers.
amounts of native activation lysate, BSA, or ovalbumin
Similar results were obtained (data not shown) when
had no effect (Figure 3A). This increased DNA-bindinglysate was first heat-shocked and then incubated at
activity was due to HSF1 (Figures 3B and 3C). To ruleroom temperature or threshold heat shock temperature.
out that the observed activation of HSF1 was causedThus, HSF1 trimers are not efficiently disassembled by
by residual urea or other chemicals, a preparation ofactivation lysate as used here. Activation of HSF1 ap-
CM-BSA was diluted severalfold and reconcentratedpears to result exclusively from an increased rate of
using a Centricon 30 Microconcentrator. The volumefactor trimerization.
of the pass-through fraction was also reduced to the
original volume of the protein preparation by lyophiliza-Activation of HSF1 In Vitro by Geldanamycin
tion. Reconcentrated protein fraction but not pass-and Denatured Proteins
through fraction greatly stimulated DNA-binding activityAddition to activation lysate of geldanamycin but not
(Figure 3D). It is interesting to note that the relative con-of analogues macbecin II and 1,9-formyl geldanamycin
centration of denatured protein at which activation ofdrastically enhanced HSE DNA-binding activity (Figure
HSF1 occurs in vitro (0.5%±1.5% of total protein) is simi-2A). That this increase in DNA-binding activity reflected
lar to that previously estimated to be required to triggeractivation of HSF1 was documented by HSF1 antibody
Hsp expression in vivo (1%±2%; Lepock et al., 1993).supershift (Figure 2B) and native anti-HSF1 blot (Figure
To learn whether HSF1 activation was mediated by2C). Activation was not inhibited by strongly reducing
soluble, nonnative proteins or by protein aggregates,conditions (Figure 2D). Thus, activation of HSF1 by gel-
a preparation of CM-BSA was subjected to a 30 mindanamycin in vitro most likely results from a reduced
centrifugation at 100,000 3 g. About 50% of protein wasactivity of Hsp90 and not from oxidativeprotein damage.
found in the pellet fraction. Similar amounts of proteinGeldanamycin activated HSF1 at threshold heat shock
from the pellet and soluble fractions were incubatedtemperature but not at room temperature (Figures 2B
with activation lysate. Only soluble, nonnative proteinsand 2C), even though the compound is known to bind
caused significant activation of HSF1 DNA-binding ac-effectively to Hsp90 and to disrupt p23 complexes at
the latter temperature (Whitesell et al., 1994; Smith et tivity (Figure 3D).
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Figure 3. Activation of HSF1 by Nonnative Proteins
(A,B, and D) EMSA.
(C) Native anti-HSF1 blot. BSA, bovine serum albumin; CM-BSA,
denatured, carboxymethylated BSA; Extract, activation lysate; CM-
extract, denatured, carboxymethylated lysate. All protein fractions
were added at final concentrations of 0.4 mg/ml. See Figure 1 for
other details.
Hsp90 Retains HSF1 in the Inactive,
Nontrimeric State
To test whether chaperones Hsp90 and Hsp/c70 could
suppress heat activation of HSF1, purified chaperones
were added (at 2 mg/ml in the experiments shown) to
activation lysate, and reactions were exposed to thresh-
old heat shock. Control reactions included ovalbumin Figure 4. Effects of Increased or Reduced Levels of Hsp90 andHsp/
c70 on HSF1 Activationinstead of a chaperone. Hsp90 severely inhibited induc-
(A and B) EMSA of lysate incubated in the presence of 2 mg/mltion of HSF1 DNA-binding activity (Figures 4A and 4B).
ovalbumin (OVA), Hsc70, Hsp70, or Hsp90.Inhibition by Hsc70 and Hsp70 was weak and variable.
(C) Native anti-HSF1 blot.As reported previously (Abravaya et al., 1992; Baler et
(D and E) First Hsp90 depletion experiment. (D) Anti-Hsp90 Western
al., 1992), DNA-HSF1 complexes in reactions containing blot. (E) EMSA of antibody-treated lysates. Hsp90 Ab 1 Hsp90: 1
added Hsp/c70 are retarded because of binding of Hsp/ mg/ml purified Hsp90 (2 mg/ml in the second experiment) added to
c70 to trimeric HSF1. Addition of Hsp90 to activation Hsp90-depleted lysate prior to threshold heat shock.
(F and G) Second Hsp90 depletion experiment. (F) Anti-Hsp90 andlysate prevented trimerization of HSF1 as well as re-
anti-actin Western blot. (G) EMSA.sulted in the abolishment of HSF1-Hsp/c70 heterodi-
(H and I) Hsp/c70 depletion experiment. (H) Anti-Hsp/c70 Westernmers (Figure 4C). This observation most likely reflects
blot. (I) EMSA.
the formation of Hsp90-containing HSF1 complex at the See text and Figure 1 for other details.
expense of HSF1 trimers and HSF1-Hsp/c70 complex.
That no new signal corresponding to Hsp90-containing
HSF1 complex appeared may be explained (see below) were removed by centrifugation. Antibody additions re-
sulted in a slight dilution (typically less than 2-fold) ofby the instability of this complex in buffers containing
salt at moderate to high concentrations (such as the reactions. Because the HSF1 trimerization reaction is
highly concentration-dependent, Hsp90 and control an-buffers used in native electrophoresis).
If Hsp90 plays a significant, nonredundant role in re- tibody-treated lysates were reconcentrated to the origi-
nal protein concentration by lyophilization. Incubationtaining HSF1 in the inactive state, immunodepletion of
Hsp90 from activation lysate would be expected to re- with Hsp90 antibody reduced the concentration of
Hsp90 by about 80% (Figures 4D and 4F). Similar ali-sult in factor activation. Results from two immunodeple-
tion experiments are presented in Figures 4D±4G. These quots of Hsp90 and control antibody-treated lysates
were exposed to threshold heat shock and then assayedexperiments were selected from nine independent ex-
periments to show maximal and minimal activating ef- by EMSA (Figures 4E and 4G). On average, Hsp90 anti-
body-treated lysate exhibited about 10-fold higher HSEfects observed. Parallel reactions were incubated on ice
for 4 hr with immobilized Hsp90 antibody AC88 and DNA-binding activity than control antibody-treated lysate.
Induced DNA-binding activity in Hsp90 antibody-treatedisotype-matched control antibody Cd11c, respectively.
Note that antibody AC88 is known to prefer free over lysate was supershifted quantitatively by anti-HSF1 anti-
body (Figure 4G). Deregulation of HSF1 DNA-bindingcomplexed Hsp90. At the end of reactions, antibodies
HSF1 Regulation by Hsp90
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activity could be prevented by addition of purified Hsp90
(at 1 mg/ml in Figure 4E and 2 mg/ml in Figure 4G)
to Hsp90 antibody-treated lysate prior to exposure to
threshold heat shock. We conclude from these results
that Hsp90 plays a nonredundant role in keeping HSF1
in the inactive, nontrimeric state, that is, in repressing
HSF1 activation. The results also imply that the interac-
tion between inactive HSF1 and Hsp90 is dynamic. In
additional experiments (data not shown) in which Hsp90
and control antibody-treated lysates were mixed at dif-
ferent ratios prior to incubation, we observed that a
40%±50% reduction of the level of Hsp90 was sufficient
to cause detectable activation of HSF1.




In light of the dramatic activating effect of Hsp90 deple-
tion, it appeared unlikely that Hsp/c70 could function
as an independent HSF1 repressor of similar importance
as Hsp90. However, Hsp/c70 is also a constituent of
Hop complex. This and other Hsp90-containing multi-
chaperone complexes exist in dynamic equilibria with
their respective constituents. If Hsp90 repressed HSF1
activation only in the context of Hop complex, depletion
of any essential constituent of this complex (i.e., Hsp90,
Hop, and Hsp/c70) should result in dissociation of the
complex and in deregulation of HSF1 activity. To test Figure 5. Immunodepletion of Different Constituents of Hsp90-Con-
this possibility, activation lysate was incubated with taining Multichaperone Complexes
monoclonal antibody BB70 that recognizes both Hsc70 (A-D) Immunodepletion with antibodies against Hop, Hip, p23,
CyP40, and Hsp40. (A) and top parts of (C) and (D): EMSA. (B) andand Hsp70 or a control monoclonal antibody (Cd11c)
bottom parts of (C) and (D): Western blots detecting the proteinsand was reconcentrated as before. Depletion of Hsp/
indicated on the side.c70 was virtually complete (Figure 4H). EMSA of Hsp/
(E) Suppression of HSF1 activation in Hsp90-antibody-treated lysate
c70-depleted and mock-depleted lysates exposed to by Hsp70 (2 mg/ml) and Hsp90 (2 mg/ml) added prior to incubation
threshold heat shock revealed that removal of Hsp/c70 under threshold heat shock conditions. Rabbit serum served as
did not deregulate HSF1 activity (Figure 4I). Exposure control for Hsp40, CyP40, and HSF1 antibodies, and mouse mono-
clonal antibody Cd11c for Hop, Hip, and p23 antibodies.to higher temperature (heat shock condition) induced
similarly elevated levels of HSF1 DNA-binding activity
in the two lysates (Figure 4I). Thus, Hsp/c70- and, by lysate. Steroid receptor complexes, which are similarly
extension, Hsp90-containing Hop complexes appear dynamic, were previously found to be reasonably stable
not to be independent repressors of HSF1 activation. in extract prepared in buffer containing little salt and
Similar immunodepletion experiments were also carried lacking detergent (Sanchez et al., 1990). Using similar
out using antibodies against Hop and Hop complex± conditions, we recently succeeded in coimmunoprecipi-
associated protein Hip. Again, even though the concen- tating HSF1 from extract of unstressed cells using an
trations of Hop and Hip could be reduced to low levels Hsp90 antibody (data not shown). To obtain evidence
(Figures 5B and 5D), no significant activation of HSF1 that the mechanism of HSF1 repression delineated by
occurred (Figures 5A and 5D). Immunodepletion (Fig- the above in vitro experiments can operate in the cell, we
ures 5B and 5C) of two constituents of p23 complexes, wished to demonstrate that Hsp90-containing (inactive)
p23 and CyP40, similarly failed to activate HSF1 (Figures HSF1 complex is formed in the cell. In the experiment
5A and 5C). Thus, neither Hop nor p23 complexes, nor shown in Figure 6A, unstressed HeLa cell cultures were
their individual constituents (other than Hsp90), play exposed to the chemical cross-linker dithiobis(succini-
nonredundant roles in repressing HSF1 activity. Analo- midyl propionate) for 5 min. As indicated by trypan blue
gous observations were also made for Hsp40 (Figures staining, the integrity of cells was preserved under the
5A and 5B). conditions used. Cross-linking reagent was rapidly re-
moved, cells were harvested, and extract was prepared.
Hsp90-containing complexes were pulled down underHsp90-Containing HSF1 Complex Forms in the Cell
and Dissociates Rapidly during Stress stringent conditions using Hsp90 antibody 9D2 (or, in
experiments not shown, Hsp90 antibody H9010 pro-As discussed before, the interaction between HSF1 and
Hsp90 appears to be dynamic. In agreement with this vided by David Toft). After reversal of cross-linking, im-
munoprecipitated proteins were analyzed by anti-HSF1notion, we were consistently unable to immunoprecipi-
tate an Hsp90-containing HSF1 complex from activation and anti-Hsp90 blot. Results showed that HSF1 was
Cell
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activation of HSF1 by different benzoquinone ansamy-
cins was compared in vivo and in vitro. Geldanamycin
but not macbecin II and 1,9-formyl geldanamycin was
found to activate HSF1 in vitro under strongly reducing
conditions (Figures2A and 2D). The experiment inFigure
6C revealed that the relative potencies (for HSF1 activa-
tion) of the three compounds are similar in vivo and in
vitro, suggesting that they act in vivo as they do in vitro.
To demonstrate that geldanamycin can activate HSF1
in vivo under conditions in which oxidation of the intra-
cellular environment cannot occur, cells were preincu-
bated for 2 hr in the presence of 1 mM DTT (conditions
adapted from Huang et al., 1994). At this relatively high
concentration of reducing agent, protein synthesis is
severely inhibited (data not shown). Inhibition of protein
synthesis is known to substantially raise the threshold
for stress activation of HSF1, presumably because of
an increased availability of chaperones for processesFigure 6. Hsp90-Containing HSF1 Complex in the Unstressed Cell,
other than protein synthesis (Baler et al., 1992). To com-and Activation of HSF1 by Benzoquinone Ansamycins In Vivo
pensate for this change in setpoint, cells were shifted(A) Immunoprecipitation of in situ-cross-linked Hsp90-containing
HSF1 complex. After reversal of cross-linking, immunoprecipitated to 428C at the end of the preincubation period. As shown
protein was analyzed by anti-HSF1 and anti-Hsp90 Western blot. in Figure 6D, preincubation with DTT and, reproducing
On top: antibodies used in immunoprecipitation; RRL HSF1: earlier observations, with cycloheximide prevented acti-
35S-methionine-labeled, underphosphorylated HSF1 synthesized in
vation of HSF1 DNA-binding activity at 428C. Exposurevitro. On the bottom: HS: 5 min/458C heat shock; DSP: cross-linker
(for 45 min) of preincubated cells to geldanamycindithiobis(succinimidyl propionate).
strongly induced DNA-binding activity. Thus, geldana-(B) Native anti-HSF1 blot of extracts from unstressed or heat-
shocked (5 min/458C) cells. mycin can activate HSF1 in a reducing intracellular envi-
(C) EMSA of extracts from cells exposed for 90 min to the com- ronment. Protein synthesis is not required for this acti-
pounds (at 1 mg/ml) indicated. vation.
(D) EMSA of extracts from cells exposed as indicated on top. Final
concentrations: DTT, 1 mM; GA, 1 mg/ml; CHM, 50 mg/ml. See previ-
Discussionous figures for other details.
Our evidence for a role of Hsp90 in the repression of
HSF1 activation is threefold. First, immunodepletion of
present in immunoprecipitated complexes. Control im-
Hsp90 results in drastic enhancement of HSF1 activity
munoprecipitations in which the Hsp90 antibody was
upon incubation of depleted lysate under threshold acti-
substituted by an isotype-matched control antibody, or
vation conditions. Purified Hsp90 suppresses this de-
omitted, failed to recover HSF1. Furthermore, HSF1
regulation of HSF1 activity (Figures 4D±4G). While these
could not be coimmunoprecipitated from extract of na-
results were obtained from experiments that monitored
ive cells. These data indicate that Hsp90-containing
deregulation of HSF1 activity at 278C±298C (threshold
HSF1 complex is formed in the cell. That HSF1 was
heat shock), analogous immunodepletion experiments
quantitatively present in the inactive, nontrimeric form
confirmed that Hsp90 can also function as HSF1 repres-
in the unstressed cells (Figure 6B) strongly suggests
sor at 378C, the normal temperature of the human cell
that the complex includes inactive HSF1. To find out
(data not shown). The latter experiments were carried
whether HSF1 is released from the complex during
out with 2-fold diluted activation lysate. This dilution
stress, relative amounts of complex were compared in
reduced the rate of HSF1 activation at 378C to about
unstressed cells and cells exposed to a 5 min 458C heat
that typically observed at 278C±298C. Second, addition
shock (Figure 6A). The complex was virtually absent in
of Hsp90 to the in vitro system suppresses activation
the heat-treated cells, and essentially all HSF1 was in
of HSF1 by threshold heat shock (Figures 4A and 4B),
the trimeric form (Figure 6B). Thus, Hsp90-containing
geldanamycin (Figure 2E), and chemically denatured
HSF1 complex dissociates during stress, and complex
BSA (not shown). Finally, Hsp90-specific compound
dissociation and HSF1 trimerization are closely corre-
geldanamycin activates HSF1 in vitro as well as in
lated events.
vivo under strongly reducing conditions in which the
compound cannot cause protein oxidation (Figures 2D
HSF1 Activation by Benzoquinone and 6D).
Ansamycins In Vivo Several independent lines of experimentation support
Susceptibility of a process tobenzoquinone ansamycins ourconclusion that Hsp90 forms a complex with inactive
such as geldanamycin is generally accepted as strong HSF1 and is released from this complex during stress.
evidence for an involvement of Hsp90 in the process. First, assays of protease sensitivity of HSF1 in activation
However, since the compounds can also act as redox lysate suggested that inactive HSF1 is bound by a factor
cyclers and may cause oxidative protein unfolding, they that can be released by geldanamycin (Figure 2F). Since
may not reliably indicate the participation of Hsp90 in geldanamycin is a specific Hsp90-binding compound,
a mechanism such as the heat shock response that is this factor is likely to be identical with Hsp90 or Hsp90-
containing chaperone complex(es). Second, a typicallytriggered by nonnative protein. To address this concern,
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be activatable when associated with a multichaperone
complex (Hutchison et al., 1995; Smith et al., 1995). Fu-
ture work will need to examine whether Hop and p23
complexes can interchangeably function as HSF1 re-
pressors. Alternatively, Hsp90 may repress HSF1 activa-
tion in the context of a yet undiscovered multichaperone
complex.
Two observations appear to be inconsistent with a
role of Hsp70 as a major HSF1 repressor. First, virtually
quantitative depletion of both Hsp70 and Hsc70 from
activation lysate fails to cause deregulation of HSF1
activity. Second, reduction of the level of Hsp90 mas-
sively activates HSF1. Thus, there appears to be little
opportunity for Hsp/c70 to function as an independent
HSF1 repressor of consequence. Still, a small fraction
of inactive HSF1 is found in a binary complex with Hsp/
c70 in cell extracts (Rabindran et al., 1994; Baler et
al., 1996; see also Nunes and Calderwood, 1995). The
Figure 7. Hsp90 Model of Regulation of HSF1
assembly of mature Hsp90-containing steroid receptor
Repressor is represented here as an Hsp90-containing complex. complex has been portrayed as an ordered process
Differences in grayscale indicate differences in relative concentra-
initiated by binding of Hsp70 to receptor (Smith, 1993;tions of proteins/complexes.
Smith et al., 1995). By analogy, we suggest that forma-
tion of HSF1-Hsp/c70 complex may be a required initialminor fraction of inactive HSF1 is associated with Hsp/
step leading to the formation of an Hsp90-containingc70 in activation lysate. Addition of Hsp90 displaces
HSF1 complex, from which HSF1 can be activated. Con-Hsp/c70 from HSF1 (Figure 4C). This is likely to reflect
ceivably, HSF1 may be prevented from trimerizing asthe formation of an Hsp90-containing HSF1 complex
soon as it associates with Hsp/c70. To test this notionat the expense of HSF1-Hsp/c70 complex. Recently,
in a situation in which mature HSF1 complex does notstabilizing conditions were identified under which Hsp90-
form efficiently and a large fraction of inactive HSF1containing HSF1 complex can be immunoprecipitated
should be available for binding Hsp/c70, an experiment(data not shown). Finally, Hsp90-containing HSF1 com-
was performed using Hsp90-depleted lysate (Figure 5E).plex can be stabilized in the cell by cross-linking. Upon
Addition of Hsp70 to this lysate prevented activation,heat treatment of cells, the complex dissociates rapidly,
albeit less efficiently than back addition of Hsp90. Thus,and HSF1 trimers form (Figures 6A and 6B).
it does appear that HSF1 associated with Hsp/c70 isHsp90-containing HSF1 complex is dynamic. As dis-
unavailable for trimerization. This result may provide forcussed before, the complex is normally unstable and
an explanation for the observation that overexpressioncan only be isolated under conditions known to stabilize
of Hsp70 renders cells somewhat refractory to heat acti-Hsp90 interactions. Furthermore, that immunodepletion
vation of HSF1 DNA-binding or transcriptional activityof Hsp90 results in HSF1 activation implies that HSF1-
(Mosser et al., 1993; Baler et al., 1996; but see alsobound Hsp90 is in rapid equilibrium with unbound
Rabindran et al., 1994) as well as for analogous findingsHsp90. Our findings are summarized in the following
made by Xiao and DeFranco (1997). Note, however, thatmodel of regulation of HSF1 activation (Figure 7). In the
the latter findings may be explained differently.unstressed cell, most HSF1 molecules are present in
an Hsp90-containing complex(es) (which may further
Experimental Proceduresinclude other chaperones and associating proteins as
indicated in the figure). HSF1 complex(es) continuously
Preparation of In Vitro Activation System
dissociates and reassembles. Upon stress, nonnative Adherent human HeLa cells were grown to 80% confluence in 150
proteins accumulate and compete with HSF1 for binding mm dishes in Dulbecco's modified Eagle medium (DMEM [high glu-
to Hsp90 or Hsp90 multichaperone complex(es). As a cose]) supplemented with 10% fetal calf serum and antibiotics (peni-
cillin and streptomycin, both at 100 IU/ml) at 378C and under 5%result, the cycle of HSF1 complex assembly and dissoci-
CO2. Cells were scraped off 30 culture dishes in a minimal volumeation is interrupted, and unbound HSF1 polypeptide ac-
of DMEM at room temperature, combined, and collected by centrifu-cumulates. In this situation, both because of the in-
gation (5 min at 750 3 g). Cell pellet was cooled on ice and washedcreased concentration of unbound HSF1 and because
twice with ice-cold reaction buffer (10 mM HEPES [pH 7.5], 0.13 M
the competing pathway (reassembly of HSF1 com- NaCl, 5 mM KCl, 10 mM MgCl2, 0.1 mM dithiothreitol [DTT], 0.3 mM
plex[es]) is effectively blocked, HSF1 trimerization is PMSF). Washed cell pellet was transferred to a loose fitting Dounce
strongly favored. homogenizer, and cells were homogenized by 30 strokes. Lysate
was subjected to three successive centrifugations, each for 10 minWe are uncertain as to whether Hsp90 can function
at 10,000 3 g. Supernatant solution (about 300 ml) was aliquoted,as a repressor of HSF1 by itself or only in the context of
quick-frozen in liquid nitrogen, and stored at 2708C. Lysates con-multichaperone complexes (i.e., Hop or a p23 complex).
tained 25±40 mg/ml protein as estimated by Dc Protein Assay (Bi-Immunodepletion of constituents of Hop and p23 com-
orad Laboratories, Melville, NY).
plexes other than Hsp90 does not activate HSF1, sug-
gesting that none of these complexes plays a nonredun- Activation In Vitro
dant role in repressing HSF1 activation. However, a Lysate was thawed on ice and supplemented with ATP-regenerating
substantial fraction of Hsp90 is present in multichaper- system (10 mM creatine phosphate, 50 mg/ml creatine phosphoki-
nase) from 1003 stock solutions of creatine phosphate and creatineone complexes, and steroid receptors appear only to
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phosphokinase. Lysate containing ATP-regenerating system is re- monoclonal Hsp90 antibody 9D2 (Lai et al., 1984) and isotype-
matched control monoclonal antibody Mac 1 (Boehringer Mann-ferred to herein as activation lysate. Typically, reactions containing
9 ml of activation lysate were preincubated for 20 min at room tem- heim) were used for immunoprecipitation, and the rabbit anti-HSF1
antibody described by Rabindran et al. (1991) for Western blot de-perature. After additions (1±2 ml), reactions were incubated in a
waterbath for 1 hr at 278C±298C (threshold activation/heat shock tection of HSF1. Both the HSF1 antibody and 9D2 were obtained
from StressGen Biotechnologies Corp.temperature). Subsequent to incubation, reactions were cooled in
ice water and kept on ice. In most experiments, aliquots of 1 ml
were tested by EMSA or native anti-HSF1 blot. Protease Sensitivity Assay
Activation lysate was preincubated at room temperature for 15±20
min with or without geldanamycin. One microliter of a solution ofPreparation of Hsps for Use in In Vitro Activation Assays
chymotrypsin (62.5 mg/ml) in reaction buffer was then added to 10Sephadex G25 spin columns (Boehringer Mannheim Corp., India-
ml of activation lysate, which was then incubated further at roomnapolis, IN) were blocked and equilibrated in 0.43 reaction buffer
temperature. Aliquots of 1±2 ml were removed at intervals into 9containing 2 mg/ml bovine serum albumin (BSA). Purified bovine
ml of SDS-PAGE sample buffer and immediately boiled for 5 min.Hsp90, bovine Hsc70, and recombinant human Hsp70 (obtained in
Samples were analyzed by anti-HSF1 Western blot.lyophilized form from StressGen Biotechnologies Corp., Victoria,
BC) were reconstituted in water to concentrations of 2 mg/ml. Ali-
quots of 50 ml were added to preequilibrated spin columns, which Recombinant HSF1
For preparation of bacterially expressed HSF1, a full-length humanwere centrifuged at 1,000 3 g for 2 min at room temperature. Eluates
(about 50 ml) were concentrated by lyophilization to 5 ml, resulting HSF1-coding sequence (Baler et al., 1993) was subcloned into vec-
tor pGEX-2T (Pharmacia, Piscataway, NJ). Glutathione-HSF1 fusionin Hsp stock solutions with concentrations close to 20 mg/ml in
43 reaction buffer. These stocks were diluted 10- to 20-fold into protein was expressed in E. coli BL21 and purified on glutathione
beads (Glutathione Sepharose 4B, from Pharmacia). Bound fusionactivation reactions, which increased the buffer concentration in
reactions to maximally 1.43 reaction buffer. Preliminary experi- protein was treated with bovine thrombin (Pharmacia) to release
full-length HSF1. For preparation of baculovirus-expressed HSF1,ments demonstrated that activatability of HSF1 was maintained at
buffer concentrations as high as 2.03. a DNA sequence encoding amino-terminally FLAG-tagged HSF1
(Nair et al., 1996) was transferred to baculovirus shuttle vector
VL1393 (Pharmingen, San Diego, CA), and recombinant baculovirusImmunodepletion Experiments
was isolated and stock prepared by a standard procedure (O'ReillyFor Hsp90 immunodepletion, protein A agarose beads (50 ml packed
et al., 1992). FLAG-tagged HSF1 was expressed in insect SF9 cells,beads) were preincubated with reaction buffer containing 2 mg/ml
purified on anti-FLAG M2 antibody affinity matrix (IBI, New Haven,of BSA. Half of the beads were then reacted for 4 hr at 48C with 200
CT), and released by FLAG peptide (IBI). FLAG peptide was subse-
ml of reaction buffer containing 20 mg of monoclonal Hsp90 antibody
quently removed. Amounts and purity of HSF1 preparations wereAC88 (Riehl et al., 1985), and the other half with a similar amount
estimated by SDS-PAGE and Coomassie blue staining.of control antibody, which was a monoclonal lymphocyte function
antigen 1 antibody (Cd11c). In vitro activation lysate (50 ml) was
Electrophoretic Mobility Shift Assaysincubated with the loaded antibody beads for 4 hr at 48C. After
Reactions were conducted essentially as described in Zuo et al.,removal of antibody beads, lysate was concentrated about 2-fold
1994. For HSE and LexA oligonucleotide probes see Baler et al.,by lyophilization (to restore original protein concentration). Protein
1993, and Zuo et al., 1994, respectively. Samples tested were eitherconcentration was verified by Protein Assay, and adjustment was
activation lysate or, in the case of in vivo experiments, extract pre-made as necessary by addition of a small volume of water. The
pared by repeated freezing and thawing of cells in high-salt buffersame protocol was used for immunodepletion of other chaperones
essentially as described in Baler et al., 1993. For HSF1 supershiftand associating proteins. When rabbit sera were used (CyP40,
experiments, 0.5 ml of anti-HSF1 serum (Baler et al., 1993) or preim-Hsp40, preimmune), 25 ml protein A (packed) beads were loaded
mune rabbit serum were added to 10 ml binding reactions at thewith 5 ml of serum. Antibodies: F5 (Hop; Smith et al., 1993), JJ5 (p23;
end of incubations. Reactions were analyzed by electrophoresis onJohnson et al., 1994), BB70 (Hsp/c70; Smith et al., 1993), 2G6 (Hip;
4.5% PAGE gels in TGE buffer (40 mM Tris-base, 400 mM glycine,Prapapanich et al., 1996), Hsp40 antibody (polyclonal; Hattori et al.,
2 mM EDTA). Gels were dried and exposed for autoradiography.1993), and CyP40 antibody (polyclonal; PA3±022). AC88 and BB70
were from StressGen Biotechnologies Corp., Cd11c from Boeh-
ringer Mannheim Corp., PA3±022 from Affinity Bioreagents, Inc., Native Anti-HSF1 Blots and Western Blots
For native PAGE, typically 1 ml of activation lysate or, in the caseGolden, CO, and actin antibody from Amersham Corp., Arlington
Heights, IL. of in vivo experiments, cell extract prepared as described above
was added to 10 ml of EMSA buffer, and the solution was applied
to a limiting pore size gel in TGE buffer. Electrophoresis, blotting,Cross-linking In Situ
and immunodetection were performed as described previouslyCultures of human HeLa cells were grown as described before. Heat
(Baler et al., 1993; Zuo et al., 1994). Immunoblots of SDS-PAGE gelstreatment was by incubation in a 458C water bath. Cultures (in 150
were prepared analogously. For all HSF1 blots, except those inmm dishes) were washed twice with phosphate-buffered saline
Figure 6, and antibody supershift assays the polyclonal HSF1 anti-(PBS) and then incubated for 5 min at room temperature with PBS
body characterized by Baler et al. (1993) was used. In addition to(8 ml) containing 2 mM dithiobis(succinimidyl propionate) in DMSO
HSF1 (75±80 kDa), this antibody recognizes two other HeLa proteinsor DMSO only. Cross-linker was quenched by addition of 10 mM
with subunit MW of 110 kDa and 57 kDa, respectively, in Westernglycine. Cells were washed once with PBS and then harvested and
blots. Note that the latter proteins are not seen by the antibody inlysed by incubation for 15 min on ice with RIPA buffer (50 mM Tris-
their native conformations (Baler et al., 1993).HCl [pH 8.0], 0.15 M NaCl, 1% NP-40, 0.1% SDS, 0.5% deoxycholic
acid, and protease inhibitors [ªCompleteº; Boehringer Mannheim]).
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